Literature DB >> 19060544

Cellular immune responses to BK virus.

Patrizia Comoli1, Hans H Hirsch, Fabrizio Ginevri.   

Abstract

PURPOSE OF REVIEW: Defects in cellular immunity to persistent viral infections are associated with an increased frequency and severity of viral diseases after transplantation. Polyomavirus BK (BKV) infection has emerged as an important cause of virus-related nephropathy after kidney allograft. Cell-mediated immunity seems to have a central role in preserving BKV latency. However, characterization of BKV-specific immunity has only recently begun. RECENT
FINDINGS: Immune responses to BKV are not fully understood, but pioneer work points to cell-mediated immunity as a critical factor for the control of viral replication and recovery from BKV disease.
SUMMARY: Advances in immunological techniques will provide further insight into the specificity and patterns of cellular response to BKV, which should assist translation into improved patient management and development of immunotherapeutic approaches.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19060544     DOI: 10.1097/MOT.0b013e3283186b93

Source DB:  PubMed          Journal:  Curr Opin Organ Transplant        ISSN: 1087-2418            Impact factor:   2.640


  26 in total

Review 1.  Polyomavirus-associated nephropathy.

Authors:  Cristina Costa; Rossana Cavallo
Journal:  World J Transplant       Date:  2012-12-24

Review 2.  BK polyomavirus infection and nephropathy: the virus-immune system interplay.

Authors:  Nina Babel; Hans-Dieter Volk; Petra Reinke
Journal:  Nat Rev Nephrol       Date:  2011-05-24       Impact factor: 28.314

3.  Early identification of renal transplant recipients with high risk of polyomavirus-associated nephropathy.

Authors:  K Teutsch; F Schweitzer; E Knops; R Kaiser; H Pfister; J Verheyen; H Göbel; T Cingöz; V Di Cristanziano
Journal:  Med Microbiol Immunol       Date:  2015-03-07       Impact factor: 3.402

Review 4.  Monitoring and managing viral infections in pediatric renal transplant recipients.

Authors:  Patrizia Comoli; Fabrizio Ginevri
Journal:  Pediatr Nephrol       Date:  2011-02-26       Impact factor: 3.714

Review 5.  Challenges of T cell therapies for virus-associated diseases after hematopoietic stem cell transplantation.

Authors:  Ann M Leen; Tamara Tripic; Cliona M Rooney
Journal:  Expert Opin Biol Ther       Date:  2010-03       Impact factor: 4.388

6.  Antigen-specific T cell responses to BK polyomavirus antigens identify functional anti-viral immunity and may help to guide immunosuppression following renal transplantation.

Authors:  A Chakera; S Bennett; S Lawrence; O Morteau; P D Mason; C A O'Callaghan; R J Cornall
Journal:  Clin Exp Immunol       Date:  2011-06-14       Impact factor: 4.330

Review 7.  Preventing stem cell transplantation-associated viral infections using T-cell therapy.

Authors:  Ifigeneia Tzannou; Ann M Leen
Journal:  Immunotherapy       Date:  2015-08-07       Impact factor: 4.196

8.  Activity of broad-spectrum T cells as treatment for AdV, EBV, CMV, BKV, and HHV6 infections after HSCT.

Authors:  Anastasia Papadopoulou; Ulrike Gerdemann; Usha L Katari; Ifigenia Tzannou; Hao Liu; Caridad Martinez; Kathryn Leung; George Carrum; Adrian P Gee; Juan F Vera; Robert A Krance; Malcolm K Brenner; Cliona M Rooney; Helen E Heslop; Ann M Leen
Journal:  Sci Transl Med       Date:  2014-06-25       Impact factor: 17.956

9.  Bright Field Microscopy to Detect Decoy Cells Due to BK Virus Infection in the Fresh and Unstained Urine Sediment in Kidney Allograft Recipients.

Authors:  José A T Poloni; Gabriel G Pinto; Maria S B Giordani; Elizete Keitel; Nadiana Inocente; Carlos F Voegeli; Giovanni B Fogazzi; Alessandro C Pasqualotto; Liane N Rotta
Journal:  J Clin Lab Anal       Date:  2016-04-28       Impact factor: 2.352

10.  Nucleofection of DCs to generate Multivirus-specific T cells for prevention or treatment of viral infections in the immunocompromised host.

Authors:  Ulrike Gerdemann; Anne S Christin; Juan F Vera; Carlos A Ramos; Yuriko Fujita; Hao Liu; Dagmar Dilloo; Helen E Heslop; Malcolm K Brenner; Cliona M Rooney; Ann M Leen
Journal:  Mol Ther       Date:  2009-07-07       Impact factor: 11.454

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.